Humacyte Inc. (NASDAQ: HUMA) Stock Information | RedChip

Humacyte Inc. (NASDAQ: HUMA) Listen to this Section


$6.48
+0.3400 ( +5.54% ) 3.0M

Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions.

Market Data


Open


$6.48

Previous close


$6.14

Volume


3.0M

Market cap


$773.40M

Day range


$6.13 - $6.69

52 week range


$1.96 - $9.97

Insider Ownership Transactions

Total Amount Purchased: -539,389.00 | $ -3,495,240.72

Date Type Amount Purchased Purchaser
2024-06-17 Sale -50000.00 Dougan Brady W
2024-06-17 Sale -75000.00 Jones Keith Anthony
2024-06-17 Sale -50000.00 Green Charles Bruce
2024-06-17 Sale -50000.00 Brown Emery N.
2024-06-17 Sale -75000.00 Bamforth John Philip
2024-06-17 Sale -50000.00 Wallace Max N.
2024-06-17 Sale -39389.00 Sebelius Kathleen
2024-06-17 Sale -50000.00 Constantino Michael T.
2024-06-17 Sale -50000.00 Niklason Laura E
2024-06-17 Sale -50000.00 Pope Todd

SEC Fillings


Form Type Description Pages Date
4 Insider transactions 1 Aug 15, 2024
10-q Quarterly Reports 78 Aug 13, 2024
8-k 8K-related 18 Aug 13, 2024
8-k 8K-related 16 Jul 31, 2024
4 Insider transactions 1 Jun 17, 2024
4 Insider transactions 1 Jun 17, 2024
4 Insider transactions 1 Jun 17, 2024
4 Insider transactions 1 Jun 17, 2024
4 Insider transactions 1 Jun 17, 2024
3 Insider transactions 2 Jun 17, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.